Literature DB >> 28157681

Plasma cell myeloma with anaplastic transformation.

Shenon Sethi1, Ira Miller1.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 28157681     DOI： 10.1182/blood-2016-08-731844

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  6 in total

1.  CD38-Negative Myeloma with Anaplastic Morphology at Presentation: A Case Report.

Authors:  Neha Singh; Narendra Agrawal; Anurag Mehta; Ajit Panaych; Radhika Sekhri
Journal:  Indian J Hematol Blood Transfus       Date:  2017-10-10       Impact factor: 0.900

2.  Successful outcome of anaplastic multiple myeloma with lenalidomide, cyclophosphamide, and dexamethasone therapy.

Authors:  Wenjiao Tang; Yangfan Xu; Bing Xiang
Journal:  Ann Hematol       Date:  2020-09-02       Impact factor: 3.673

3.  Morphological Transformation of Myeloma Cells into Multilobated Plasma Cell Nuclei within 7 Days in a Case of Secondary Plasma Cell Leukemia That Finally Transformed as Anaplastic Myeloma.

Authors:  Akihito Fujimi; Yasuhiro Nagamachi; Naofumi Yamauchi; Yuji Kanisawa
Journal:  Case Rep Hematol       Date:  2017-12-21

4.  Pleomorphic Multinucleated Plasma Cells Simulating Megakaryocytes in an Anaplastic Variant of Myeloma.

Authors:  Shivangi Harankhedkar; Ruchi Gupta; Khaliqur Rahman
Journal:  Turk J Haematol       Date:  2018-02-06       Impact factor: 1.831

5.  Anaplastic Multiple Myeloma: Case Series and Literature Review.

Authors:  Jian Wu; Emily Chu; Cristiana Costa Chase; Taewoong Choi; Cristina Gasparetto; Ken Young; Yubin Kang
Journal:  Asploro J Biomed Clin Case Rep       Date:  2022-01-15

6.  Poor response to daratumumab and carfilzomib in newly diagnosed anaplastic multiple myeloma.

Authors:  Masuho Saburi; Masao Ogata; Yasuhiro Soga; Yoshiyuki Kondo; Ryo Kurimoto; Kazuhito Itani; Kazuhiro Kohno; Hiroki Uchida; Toshiyuki Nakayama
Journal:  J Clin Exp Hematop       Date:  2020
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.